Listed

Milestone Scientific Inc.

MLSSNYSECIK 855683HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.8m, Q2 FY2026
Operating income−$1.1m, Q2 FY2026
Net income−$1.1m, Q2 FY2026
Milestone Scientific Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k2,059Revenue, Q3 FY2023, three months to 2023-09-30$2.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure2,261Revenue, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure2,249Revenue, Q1 FY2024, three months to 2024-03-31$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure1,854Revenue, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure2,514Revenue, Q3 FY2024, three months to 2024-09-30$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure2,014Revenue, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure2,232Revenue, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure2,323Revenue, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure2,360Revenue, Q3 FY2025, three months to 2025-09-30$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure2,058Revenue, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure2,162Revenue, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure2,841Revenue, Q2 FY2026, three months to 2026-06-30$2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Cost of revenue$k556Cost of revenue, Q3 FY2023, three months to 2023-09-30$555.9k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure750Cost of revenue, Q4 FY2023, three months to 2023-12-31$750.1k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure573Cost of revenue, Q1 FY2024, three months to 2024-03-31$572.7k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure443Cost of revenue, Q2 FY2024, three months to 2024-06-30$442.6k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure678Cost of revenue, Q3 FY2024, three months to 2024-09-30$677.6k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure502Cost of revenue, Q4 FY2024, three months to 2024-12-31$502.5k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure585Cost of revenue, Q1 FY2025, three months to 2025-03-31$585.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure706Cost of revenue, Q2 FY2025, three months to 2025-06-30$705.9k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure719Cost of revenue, Q3 FY2025, three months to 2025-09-30$719.2k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure556Cost of revenue, Q4 FY2025, three months to 2025-12-31$556.3k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure598Cost of revenue, Q1 FY2026, three months to 2026-03-31$598.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure931Cost of revenue, Q2 FY2026, three months to 2026-06-30$930.9k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Gross profit$k1,503Gross profit, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure1,510Gross profit, Q4 FY2023, three months to 2023-12-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure1,676Gross profit, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure1,411Gross profit, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure1,836Gross profit, Q3 FY2024, three months to 2024-09-30$1.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure1,511Gross profit, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure1,647Gross profit, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure1,618Gross profit, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure1,641Gross profit, Q3 FY2025, three months to 2025-09-30$1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure1,502Gross profit, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure1,564Gross profit, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure1,910Gross profit, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Research and development$k170Research and development, Q3 FY2023, three months to 2023-09-30$170.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure177Research and development, Q4 FY2023, three months to 2023-12-31$176.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure94.2Research and development, Q1 FY2024, three months to 2024-03-31$94.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure315Research and development, Q2 FY2024, three months to 2024-06-30$315.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure232Research and development, Q3 FY2024, three months to 2024-09-30$232.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure218Research and development, Q4 FY2024, three months to 2024-12-31$217.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure369Research and development, Q1 FY2025, three months to 2025-03-31$369.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure51.8Research and development, Q2 FY2025, three months to 2025-06-30$51.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure16.2Research and development, Q3 FY2025, three months to 2025-09-30$16.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure12.3Research and development, Q4 FY2025, three months to 2025-12-31$12.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figurenot reported6.6Research and development, Q2 FY2026, three months to 2026-06-30$6.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Selling, general and administrative$k2,824Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$2.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure3,301Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure3,035Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure2,868Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure3,065Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$3.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure3,327Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure3,257Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure3,031Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure2,739Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure2,550Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure2,373Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure2,946Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Operating income$k(1,507)Operating income, Q3 FY2023, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure(1,980)Operating income, Q4 FY2023, three months to 2023-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure(1,465)Operating income, Q1 FY2024, three months to 2024-03-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure(1,780)Operating income, Q2 FY2024, three months to 2024-06-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure(1,469)Operating income, Q3 FY2024, three months to 2024-09-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure(2,042)Operating income, Q4 FY2024, three months to 2024-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure(1,998)Operating income, Q1 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(1,485)Operating income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure(1,134)Operating income, Q3 FY2025, three months to 2025-09-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure(1,080)Operating income, Q4 FY2025, three months to 2025-12-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure(828)Operating income, Q1 FY2026, three months to 2026-03-31−$828.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(1,062)Operating income, Q2 FY2026, three months to 2026-06-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-14, accession 0001437749-23-031950.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-29, accession 0001437749-24-010029. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-15, accession 0001437749-24-017036.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figurenot reportednot reportednot reported0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figurenot reportednot reportednot reportednot reported
Net income$k(1,466)Net income, Q3 FY2023, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure(1,939)Net income, Q4 FY2023, three months to 2023-12-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure(1,441)Net income, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure224Net income, Q2 FY2024, three months to 2024-06-30$223.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure(1,461)Net income, Q3 FY2024, three months to 2024-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure(2,036)Net income, Q4 FY2024, three months to 2024-12-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure(1,995)Net income, Q1 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure(1,483)Net income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure(1,154)Net income, Q3 FY2025, three months to 2025-09-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure(1,091)Net income, Q4 FY2025, three months to 2025-12-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure(840)Net income, Q1 FY2026, three months to 2026-03-31−$839.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure(1,059)Net income, Q2 FY2026, three months to 2026-06-30−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reported(0.02)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(0.02)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure(0.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figurenot reported(0.01)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(0.01)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Basic EPS$ per share(0.02)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figurenot reported(0.02)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure0.00Basic EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure(0.02)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figurenot reported(0.02)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(0.02)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure(0.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figurenot reported(0.01)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(0.01)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure

Balance sheet

Cash and equivalents$2.1m, Q2 FY2026
Shareholders' equity$3.5m, Q2 FY2026
Milestone Scientific Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31period not labelled2026-04-20Q2 FY20262026-06-30
Cash and equivalents$m3.0Cash and equivalents, FY2023, at 2023-12-31$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-04-15, accession 0001437749-25-012050.Report this figure4.0Cash and equivalents, Q1 FY2024, at 2024-03-31$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001437749-24-017036.Report this figure5.8Cash and equivalents, Q2 FY2024, at 2024-06-30$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure4.8Cash and equivalents, Q3 FY2024, at 2024-09-30$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure3.3Cash and equivalents, FY2024, at 2024-12-31$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001493152-26-014117.Report this figure2.2Cash and equivalents, Q1 FY2025, at 2025-03-31$2.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure1.3Cash and equivalents, Q2 FY2025, at 2025-06-30$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure1.3Cash and equivalents, Q3 FY2025, at 2025-09-30$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure1.1Cash and equivalents, FY2025, at 2025-12-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure1.2Cash and equivalents, Q1 FY2026, at 2026-03-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure1.8Cash and equivalents, period not labelled, at 2026-04-20$1.8m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure2.1Cash and equivalents, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Current assets$m10.8Current assets, FY2023, at 2023-12-31$10.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-04-15, accession 0001437749-25-012050.Report this figure10.8Current assets, Q1 FY2024, at 2024-03-31$10.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017036.Report this figure11.5Current assets, Q2 FY2024, at 2024-06-30$11.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure10.7Current assets, Q3 FY2024, at 2024-09-30$10.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure9.3Current assets, FY2024, at 2024-12-31$9.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014117.Report this figure8.6Current assets, Q1 FY2025, at 2025-03-31$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure7.6Current assets, Q2 FY2025, at 2025-06-30$7.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure8.1Current assets, Q3 FY2025, at 2025-09-30$8.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure7.5Current assets, FY2025, at 2025-12-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure7.4Current assets, Q1 FY2026, at 2026-03-31$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figurenot reported8.1Current assets, Q2 FY2026, at 2026-06-30$8.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Total assets$m11.4Total assets, FY2023, at 2023-12-31$11.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-04-15, accession 0001437749-25-012050.Report this figure11.4Total assets, Q1 FY2024, at 2024-03-31$11.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001437749-24-017036.Report this figure12.0Total assets, Q2 FY2024, at 2024-06-30$12.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure11.2Total assets, Q3 FY2024, at 2024-09-30$11.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure9.8Total assets, FY2024, at 2024-12-31$9.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001493152-26-014117.Report this figure9.1Total assets, Q1 FY2025, at 2025-03-31$9.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure8.1Total assets, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure8.5Total assets, Q3 FY2025, at 2025-09-30$8.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure7.8Total assets, FY2025, at 2025-12-31$7.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure8.0Total assets, Q1 FY2026, at 2026-03-31$8.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figurenot reported8.3Total assets, Q2 FY2026, at 2026-06-30$8.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Current liabilities$m3.1Current liabilities, FY2023, at 2023-12-31$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-04-15, accession 0001437749-25-012050.Report this figure3.6Current liabilities, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017036.Report this figure3.8Current liabilities, Q2 FY2024, at 2024-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure3.8Current liabilities, Q3 FY2024, at 2024-09-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure3.7Current liabilities, FY2024, at 2024-12-31$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014117.Report this figure4.4Current liabilities, Q1 FY2025, at 2025-03-31$4.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure3.8Current liabilities, Q2 FY2025, at 2025-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure5.0Current liabilities, Q3 FY2025, at 2025-09-30$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure4.1Current liabilities, FY2025, at 2025-12-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure4.9Current liabilities, Q1 FY2026, at 2026-03-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figurenot reported4.4Current liabilities, Q2 FY2026, at 2026-06-30$4.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Total liabilities$m3.4Total liabilities, FY2023, at 2023-12-31$3.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-04-15, accession 0001437749-25-012050.Report this figure3.9Total liabilities, Q1 FY2024, at 2024-03-31$3.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001437749-24-017036.Report this figure4.1Total liabilities, Q2 FY2024, at 2024-06-30$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure4.0Total liabilities, Q3 FY2024, at 2024-09-30$4.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001437749-24-035311.Report this figure4.0Total liabilities, FY2024, at 2024-12-31$4.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001493152-26-014117.Report this figure4.6Total liabilities, Q1 FY2025, at 2025-03-31$4.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure4.7Total liabilities, Q2 FY2025, at 2025-06-30$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001437749-25-026919.Report this figure5.9Total liabilities, Q3 FY2025, at 2025-09-30$5.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure5.0Total liabilities, FY2025, at 2025-12-31$5.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure5.7Total liabilities, Q1 FY2026, at 2026-03-31$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figurenot reported4.9Total liabilities, Q2 FY2026, at 2026-06-30$4.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure
Shareholders' equity$m8.0Shareholders' equity, FY2023, at 2023-12-31$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001493152-26-014117.Report this figure7.5Shareholders' equity, Q1 FY2024, at 2024-03-31$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure8.0Shareholders' equity, Q2 FY2024, at 2024-06-30$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure7.2Shareholders' equity, Q3 FY2024, at 2024-09-30$7.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure5.8Shareholders' equity, FY2024, at 2024-12-31$5.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure4.5Shareholders' equity, Q1 FY2025, at 2025-03-31$4.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure3.3Shareholders' equity, Q2 FY2025, at 2025-06-30$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure2.5Shareholders' equity, Q3 FY2025, at 2025-09-30$2.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure2.8Shareholders' equity, FY2025, at 2025-12-31$2.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure2.3Shareholders' equity, Q1 FY2026, at 2026-03-31$2.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figurenot reported3.5Shareholders' equity, Q2 FY2026, at 2026-06-30$3.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure

Cash flow

Operating cash flow−$585.1k, Q2 FY2026
Capital expenditure$4.1k, Q2 FY2026
Milestone Scientific Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,053)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001437749-24-035311. Derived: 9-month figure less the 6-month figure.Report this figure(1,246)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-04-15, accession 0001437749-25-012050. Derived: 12-month figure less the 9-month figure.Report this figure(1,218)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001437749-25-017171.Report this figure784Operating cash flow, Q2 FY2024, three months to 2024-06-30$783.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001437749-25-026919. Derived: 6-month figure less the 3-month figure.Report this figure(974)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$973.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022276. Derived: 9-month figure less the 6-month figure.Report this figure(1,511)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure(1,008)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(1,764)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037761. Derived: 6-month figure less the 3-month figure.Report this figure81.8Operating cash flow, Q3 FY2025, three months to 2025-09-30$81.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022276. Derived: 9-month figure less the 6-month figure.Report this figure(226)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$226.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure86.8Operating cash flow, Q1 FY2026, three months to 2026-03-31$86.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure(585)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$585.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037761. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reported3.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure1.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure4.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$4.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037761. Derived: 6-month figure less the 3-month figure.Report this figure6.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$6.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022276. Derived: 9-month figure less the 6-month figure.Report this figure3.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$3.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-014117. Derived: 12-month figure less the 9-month figure.Report this figure1.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure4.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037761. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)93.13m, Q2 FY2026
Milestone Scientific Inc., shares, quarterly
Line itemUnitQ3 FY20212021-09-30Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q2 FY20232023-06-30Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares69.6Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3069,573,795 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-14, accession 0001437749-22-027252.Report this figure69.0Diluted shares (weighted), Q1 FY2022, three months to 2022-03-3169,013,001 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-05-16, accession 0001437749-22-012645.Report this figure70.4Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3070,356,796 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-15, accession 0001437749-22-020528.Report this figure71.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3070,975,420 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-14, accession 0001437749-22-027252.Report this figure72.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3072,333,656 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure80.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3079,967,086 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001437749-24-026774.Report this figure80.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3079,966,833 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure81.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3181,854,512 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure82.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3082,049,984 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure82.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3082,322,910 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022276.Report this figure85.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3185,041,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022701.Report this figure93.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3093,126,415 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure

Shares outstanding: 88.74mShares outstanding, period not labelled, at 2026-08-1188,739,185 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037761.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.